miR-23a-3p has an oncogenic role in these types of cancer, with direct targeting of PGC-1α and G6PC [23], MTSS1 [24], and RKIP [25], as well as suppressor genes of both the Wnt/β-catenin signaling pathway and DNA methylation pathway in cooperation with other miRNAs in the miR-23a/24/27a cluster [26]. The gene discussed is PPARGC1A; the disease is cancer.